Skip to main content
Top
Published in: Journal of Cancer Survivorship 2/2020

01-04-2020 | Care

Survivorship objectives in comprehensive cancer control plans: a systematic review

Authors: Michelle A. Mollica, Angela L. Falisi, Ann M. Geiger, Paul B. Jacobsen, Natasha Buchanan Lunsford, Mandi L. Pratt-Chapman, Julie S. Townsend, Larissa Nekhlyudov

Published in: Journal of Cancer Survivorship | Issue 2/2020

Login to get access

Abstract

Purpose

Over a decade ago, the National Academy of Medicine (NAM) recommended that states develop, implement, and evaluate plans that include consideration of survivorship care. The purpose of this study was to review comprehensive cancer control plans in the USA, specifically to identify the inclusion of cancer survivorship-focused goals and objectives and examine alignment of survivorship-focused objectives with the NAM recommendations.

Methods

Plans from 50 states, 7 territories, 5 tribal organizations, and the District of Columbia were reviewed to assess inclusion of survivorship goals and objectives. One territory plan was excluded because it did not include a survivorship-focused goal or objective (final n = 62). Objectives were assigned to domains based on NAM survivorship recommendations.

Results

Plans included between 1 and 19 survivorship-related objectives. Of the 345 survivorship objectives extracted and analyzed, the most prevalent domains addressed were raising awareness, survivorship care plans, healthcare professional capacity, and models of coordinated care. Employment-related concerns, developing and implementing quality measures, and investments in research were not frequently included in objectives.

Conclusions

Comprehensive cancer control plans represent an important strategy that may reduce the impact of cancer and its treatment. State, territorial, and tribal coalitions can use these results to systematically focus future survivorship efforts on areas relevant to their region and population.

Implications for cancer survivors

The growing number of survivors requires broad-ranging policy strategies. Future efforts are needed to assess the implementation and impact of plan strategies to improve the overall wellness of cancer survivors.
Appendix
Available only for authorised users
Literature
2.
go back to reference Centers for Disease Control and Prevention. A national action plan for cancer survivorship: advancing public health strategies. Atlanta: Centers for Disease Control and Prevention; 2004. Centers for Disease Control and Prevention. A national action plan for cancer survivorship: advancing public health strategies. Atlanta: Centers for Disease Control and Prevention; 2004.
3.
go back to reference Buchanan N, Houston K, Richardson L. The essential role of public health in preventing disease, prolonging life, and promoting health of cancer survivors. Am J Prev Med. 2015;49(6):S467–S9.CrossRef Buchanan N, Houston K, Richardson L. The essential role of public health in preventing disease, prolonging life, and promoting health of cancer survivors. Am J Prev Med. 2015;49(6):S467–S9.CrossRef
4.
go back to reference Moore A, Buchanan N, Fairley T, Lee SJ. Public health action model for cancer survivorship. Am J Prev Med. 2015;49(6 Suppl 5):S470–6.CrossRef Moore A, Buchanan N, Fairley T, Lee SJ. Public health action model for cancer survivorship. Am J Prev Med. 2015;49(6 Suppl 5):S470–6.CrossRef
7.
go back to reference Underwood JM, Lakhani N, Finifrock D, Pinkerton B, Johnson KL, Mallory SH, et al. Evidence-based cancer survivorship activities for comprehensive cancer control. Am J Prev Med. 2015;49(6S5):S536–S42.CrossRef Underwood JM, Lakhani N, Finifrock D, Pinkerton B, Johnson KL, Mallory SH, et al. Evidence-based cancer survivorship activities for comprehensive cancer control. Am J Prev Med. 2015;49(6S5):S536–S42.CrossRef
8.
go back to reference Rohan EA, Miller N, Bonner F, et al. Comprehensive cancer control: promoting survivor health and wellness. Cancer Causes Control. 2018;29(12):1277–85.CrossRef Rohan EA, Miller N, Bonner F, et al. Comprehensive cancer control: promoting survivor health and wellness. Cancer Causes Control. 2018;29(12):1277–85.CrossRef
9.
go back to reference Bluethmann SM, Mariotto A, Rowland JH. Anticipating the “Silver Tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomark Prev. 2016;25(7):1029–36.CrossRef Bluethmann SM, Mariotto A, Rowland JH. Anticipating the “Silver Tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomark Prev. 2016;25(7):1029–36.CrossRef
11.
go back to reference Institute of Medicine. From cancer patient to cancer survivor: lost in transition. Washington, DC: Institute of Medicine; 2005. Institute of Medicine. From cancer patient to cancer survivor: lost in transition. Washington, DC: Institute of Medicine; 2005.
12.
go back to reference Kline RM, Arora NK, Bradley CJ, Brauer ER, Graves DL, Buchanan Lundsford N, et al. Long-term survivorship care after cancer treatment- summary of a 2017 National Cancer Policy Forum Workshop. J Natl Cancer Inst. 2018;110(12):1300–10.CrossRef Kline RM, Arora NK, Bradley CJ, Brauer ER, Graves DL, Buchanan Lundsford N, et al. Long-term survivorship care after cancer treatment- summary of a 2017 National Cancer Policy Forum Workshop. J Natl Cancer Inst. 2018;110(12):1300–10.CrossRef
13.
go back to reference Nekhlyudov L, Ganz P, Arora NK, Rowland JH. Going beyond being lost in transition: a decade of progress in cancer survivorship. J Clin Oncol. 2017;35(18):1978–81.CrossRef Nekhlyudov L, Ganz P, Arora NK, Rowland JH. Going beyond being lost in transition: a decade of progress in cancer survivorship. J Clin Oncol. 2017;35(18):1978–81.CrossRef
14.
go back to reference Underwood JM, Lakhani N, Rohan E, Moore A, Stewart SL. An evaluation of cancer survivorship activities across national comprehensive cancer control programs. J Cancer Surviv. 2015;9(3):554–9.CrossRef Underwood JM, Lakhani N, Rohan E, Moore A, Stewart SL. An evaluation of cancer survivorship activities across national comprehensive cancer control programs. J Cancer Surviv. 2015;9(3):554–9.CrossRef
17.
go back to reference Rochester P, Adams E, Porterfield D, Holden D, McAleer K, Steele B. Cancer plan index: a measure for assessing the quality of cancer plans. J Public Health Manag Pract. 2011;17(6):E12–E7.CrossRef Rochester P, Adams E, Porterfield D, Holden D, McAleer K, Steele B. Cancer plan index: a measure for assessing the quality of cancer plans. J Public Health Manag Pract. 2011;17(6):E12–E7.CrossRef
19.
go back to reference National Academies of Sciences Engineering and Medicine. Long-term survivorship care after cancer treatment: proceedings of a workshop. Washington, DC: The National Academies Press; 2018. National Academies of Sciences Engineering and Medicine. Long-term survivorship care after cancer treatment: proceedings of a workshop. Washington, DC: The National Academies Press; 2018.
20.
go back to reference Mayer D, Knafl G, Fitzpatrick B, Nevidjon B. The survivorship tsunami: current models of follow-up care are unsustainable. J Clin Oncol. 2018;36(7):48.CrossRef Mayer D, Knafl G, Fitzpatrick B, Nevidjon B. The survivorship tsunami: current models of follow-up care are unsustainable. J Clin Oncol. 2018;36(7):48.CrossRef
21.
go back to reference Halpern M, Argenbright K. Evaluation of effectiveness of survivorship programmes: how to measure success? Lancet Oncol 2017;18(1):PE51-E9. Halpern M, Argenbright K. Evaluation of effectiveness of survivorship programmes: how to measure success? Lancet Oncol 2017;18(1):PE51-E9.
23.
go back to reference Oeffinger K, McCabe M. Models for delivering survivorship care. J Clin Oncol. 2006;24(32):5117–24.CrossRef Oeffinger K, McCabe M. Models for delivering survivorship care. J Clin Oncol. 2006;24(32):5117–24.CrossRef
24.
go back to reference Yabroff K, Dowling EC, Guy G, Banegas M, Davidoff A, Han X, et al. Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J Clin Oncol. 2016;34(3):259–67.CrossRef Yabroff K, Dowling EC, Guy G, Banegas M, Davidoff A, Han X, et al. Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J Clin Oncol. 2016;34(3):259–67.CrossRef
27.
go back to reference Skolarus T, Wolf A, Erb N, et al. American Cancer society prostate cancer survivorship care guidelines. CA Cancer J Clin. 2014;64:225–49.CrossRef Skolarus T, Wolf A, Erb N, et al. American Cancer society prostate cancer survivorship care guidelines. CA Cancer J Clin. 2014;64:225–49.CrossRef
29.
go back to reference Jacobsen P, DeRosa A, Henderson T, Mayer D, Moskowitz C, Paskett E, et al. Systematic review of the impact of cancer survivorship care plans on health outcomes and health care delivery. J Clin Oncol. 2018;36:2088–100;(epub).CrossRef Jacobsen P, DeRosa A, Henderson T, Mayer D, Moskowitz C, Paskett E, et al. Systematic review of the impact of cancer survivorship care plans on health outcomes and health care delivery. J Clin Oncol. 2018;36:2088–100;(epub).CrossRef
30.
go back to reference Birken S, Mayer D. Survivorship care planning: why is it taking so long? J Natl Compr Canc Netw. 2017;15:1165–9.CrossRef Birken S, Mayer D. Survivorship care planning: why is it taking so long? J Natl Compr Canc Netw. 2017;15:1165–9.CrossRef
31.
go back to reference American College of Surgeons. Commission on cancer optimal resources for cancer care: 2020 standards. Chicago: American College of Surgeons; 2019. American College of Surgeons. Commission on cancer optimal resources for cancer care: 2020 standards. Chicago: American College of Surgeons; 2019.
32.
go back to reference Kirkwood M, Hanley A, Bruinooge S, Garrett-Mayer E, Levit L, Schenkel C, et al. The state of oncology practice in America, 2018: results of the ASCO practice census survey. J Oncol Pract. 2018;14(7):e412–20.CrossRef Kirkwood M, Hanley A, Bruinooge S, Garrett-Mayer E, Levit L, Schenkel C, et al. The state of oncology practice in America, 2018: results of the ASCO practice census survey. J Oncol Pract. 2018;14(7):e412–20.CrossRef
Metadata
Title
Survivorship objectives in comprehensive cancer control plans: a systematic review
Authors
Michelle A. Mollica
Angela L. Falisi
Ann M. Geiger
Paul B. Jacobsen
Natasha Buchanan Lunsford
Mandi L. Pratt-Chapman
Julie S. Townsend
Larissa Nekhlyudov
Publication date
01-04-2020
Publisher
Springer US
Keyword
Care
Published in
Journal of Cancer Survivorship / Issue 2/2020
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-019-00832-3

Other articles of this Issue 2/2020

Journal of Cancer Survivorship 2/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine